In a newly released, digitally re-mastered version of A Christmas Story, Ralphie actually get’s his eye shot out!!
Happy Holidays Beav!!
Ummmmm......... this is just a wild guess on my part! :-)
1) They’re trying to sell drugs to teenagers.
2) Truck drivers are already falling asleep at the wheel.
3) All of the 7 dwarfs are allergic to Zutripro & Rezia
4) Homoeopathists’ are using a combination of Pepto-Bismol & Align to fight HP.
5) Based on a recent poll, most woman prefer Oxytocin over OxyContin. (or is it the other way around??)
According to my Captain Marvel Decoder Ring, I am an enigma!
Hey Kitten - I had previously posted that I initially missed getting into PCYC (an lbl4321 recommendation) because it ran up so fast. So.......... when it dipped to ~$100 in mid-October, I took all of my initial SGEN investment PLUS the profit that I made PLUS some additional funds and jumped into it with all four paws.
Now, I don't have a "plug nickel" left to invest, except for a small cash residual that I'm saving for end of the year tax sell off dips on something. So......... can you do a fellow critter a favor and float me a $300-400K short term, interest free loan for a wabbitburger ???
"I would gladly pay you Tuesday [next year] for a wabbitburger today." :-)
Freddy Ferret - a wabbit's worst nightmare
Kitten – I agree. One can own both and I too hope both do well. And I also have a suggestion for you regarding options, IF you’re not already doing so. You don’t necessarily need to be trading options. You can however, watch the price and activity level of a targeted subset of them, just like one might watch the pps & volume of a stock, the level of short interest, the level of tutes ownership, etc. etc. It’s just another input to weave into you’re investment DD and/or trading.
For an example, and FWIW, on November 12th, the same day that PTX’s pps established a new 52-week high ($11.68) the open interest on Feb 2015 $10 calls for PTX was 151. Of that 151, 103 of them were purchased that day for $1.80, at an 18% discount to the preceding ones purchased.
As posted before, I tend to trade options on what I consider volatile stocks.
AS ALWAYS, ALL THE BEST…………..
Freddy Ferret - a wabbit's worst nightmare :-)
The #1 Best Thing about PTX is that Kitty found a “diamond in the ruff” before Duggie Do-Right of the Royal Turnaround Specialists, LLC appeared on the scene. The first thing Duggie did was rescue poor Nell from that slave labor factory in Texas! She was tied to bottle filling conveyer.
The #2 Best Thing about PTX is that I won a box of Rasinettes during the Kitty sponsored “Name that Company” TV game show, while we were mess’n around with VEN diagrams. They were directly shipped to Mrs. Alphalski, while she was in rehab. This was in November of 2013 when PTX’s pps was $2.XX
So much for Thing 1 and Thing 2………..
It was then discovered that Jeff (??) who invested in PTX & help bring in the new mgmt, also invested in HZPN.
So……..as of today, I sincerely believe we could create a very long thread listing the pros & cons of both companies.One could look at both companies from a tops-down, a bottoms-up, a left to right, etc, etc perspective and it would be difficult (IMO) to come out seeing a black & white winner. Each company stands on some very solid merits of their own.
And I don’t like bashing one company and pumping – but that’s just me!
I have played/am playing in both ponds and have no regrets!!
Other opinions are welcomed - please chime in........................
GOOD 4 ➜ U Beav - I love it when a plan finally comes together!!!
I suspect there will be an empty whiskey jar in Beav's lodge come morning!! :-)
Not as happy as I am curious. Does Lane Bryant make capri pants that big??
Maybe custom order from Omar the tentmaker.................... :-)
I do remember your "Flags in Cambridge". I have just about completed converting the majority of my portfolio to large caps, something I began at the beginning of the year. Using a combination of long shares & options on the smaller caps. However, like I posted to Kitty, any new investments that I have made/will make this year has to already have revenue. So far, that approach has worked well for me.
A&M seem to be the 2014 theme for biotechs this year, as opposed to FDA approvals like last year, IMO.
All the best..........